Detalhe da pesquisa
1.
SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract.
Cell
; 182(2): 429-446.e14, 2020 07 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32526206
2.
A Novel Antigenic Site Spanning Domains I and III of the Zika Virus Envelope Glycoprotein Is the Target of Strongly Neutralizing Human Monoclonal Antibodies.
J Virol
; 95(9)2021 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33597214
3.
Combining antibody markers for serosurveillance of SARS-CoV-2 to estimate seroprevalence and time-since-infection.
Epidemiol Infect
; 150: e20, 2022 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35068405
4.
Combining antibody markers for serosurveillance of SARS-CoV-2 to estimate seroprevalence and time-since-infection - CORRIGENDUM.
Epidemiol Infect
; 150: e188, 2022 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36426603
5.
Magnitude and Durability of the Antibody Response to mRNA-Based Vaccination Among SARS-CoV-2 Seronegative and Seropositive Health Care Personnel.
Open Forum Infect Dis
; 11(1): ofae009, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38293246
6.
A semi-quantitative, rapid, point of care SARS-CoV-2 serologic assay predicts neutralizing antibody levels.
bioRxiv
; 2023 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37398270
7.
Seroepidemiology and risk factors for SARS-CoV-2 infection among household members of food processing and farm workers in North Carolina.
IJID Reg
; 7: 164-169, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37034427
8.
Encephalitis Caused by Jamestown Canyon Virus in a Liver Transplant Patient, North Carolina, USA, 2017.
Open Forum Infect Dis
; 9(3): ofac031, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35187195
9.
SARS-CoV-2 seroprevalence and risk factors among meat packing, produce processing, and farm workers.
PLOS Glob Public Health
; 2(7): e0000619, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36962464
10.
Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study.
mBio
; 13(5): e0175122, 2022 10 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36135380
11.
Evaluation of a COVID-19 convalescent plasma program at a U.S. academic medical center.
PLoS One
; 17(12): e0277707, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36480499
12.
Ethnoracial Disparities in SARS-CoV-2 Seroprevalence in a Large Cohort of Individuals in Central North Carolina from April to December 2020.
mSphere
; 7(3): e0084121, 2022 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35587682
13.
SARS-CoV-2 Infection in Health Care Personnel and Their Household Contacts at a Tertiary Academic Medical Center: Protocol for a Longitudinal Cohort Study.
JMIR Res Protoc
; 10(4): e25410, 2021 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33769944
14.
Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals.
mSphere
; 6(4): e0027521, 2021 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34431693
15.
Sex disparities and neutralizing antibody durability to SARS-CoV-2 infection in convalescent individuals.
medRxiv
; 2021 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33564775
16.
Disparities in SARS-CoV-2 seroprevalence among individuals presenting for care in central North Carolina over a six-month period.
medRxiv
; 2021 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33791743
17.
Convalescent Plasma Therapy in Four Critically Ill Pediatric Patients With Coronavirus Disease 2019: A Case Series.
Crit Care Explor
; 2(10): e0237, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33063037
18.
The RBD Of The Spike Protein Of SARS-Group Coronaviruses Is A Highly Specific Target Of SARS-CoV-2 Antibodies But Not Other Pathogenic Human and Animal Coronavirus Antibodies.
medRxiv
; 2020 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32511572
19.
The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients.
Sci Immunol
; 5(48)2020 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32527802
20.
SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo.
Science
; 370(6523): 1464-1468, 2020 12 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33184236